SCHEMBL30937570

SCHEMBL30937570

N#Cc1cncc2c1CN(CC(=O)O)C(=O)N2

nearest known ligand 0.36

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ RIPK1 Q13546 11/20 0.33
▸ STAT3 P40763 1/20 0.32
▸ ITGB3 P05106 1/20 0.30
▸ ITGA2B P08514 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937665 0.82 ACE (0.47) ACEMMP13ITGB3ITGA2B
SCHEMBL30937659 0.82 ALDH1A1 (0.36) ACEMMP13RIPK1
SCHEMBL30937672 0.75 ACE (0.41) ACEMMP13STAT3
SCHEMBL30937588 0.67 ACE (0.48) ACEMMP13ITGB3ITGA2B
SCHEMBL30937524 0.66 ACE (0.44) ACEMMP13
SCHEMBL30937732 0.66 ACE (0.44) ACEMMP13
SCHEMBL30937651 0.66 ACE (0.53) ACEMMP13
SCHEMBL8345781 0.64 TSHR (0.39) ACEMMP13
SCHEMBL30937679 0.64 BRD4 (0.51) ACEMMP13
SCHEMBL30937681 0.64 ACE (0.42) ACEMMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback